منابع مشابه
[Current treatment of chronic heart failure].
Cardiovascular diseases including heart failure represent a common disease in patients referred for anesthesia. In most cases, heart failure is caused by left ventricular dysfunction due to coronary heart disease. The aims of the treatment of chronic heart failure are the relief of symptoms, the improvement of prognosis and the prevention of the progression of heart failure. The first-line trea...
متن کاملOptimized Treatment and Heart Rate Reduction in Chronic Heart Failure
BACKGROUND Heart failure (HF) is a syndrome that leads to poor outcome in advanced forms. The neurohormonal blockade modifies this natural history; however, it is often suboptimal. OBJECTIVE The aim of this study is to assess at what percentage cardiologists used to treating HF can prescribe target doses of drugs of proven efficacy. METHODS A total of 104 outpatients with systolic dysfuncti...
متن کاملCONGESTIVE HEART FAILURE Effectiveness of lmazodan for Treatment of Chronic Congestive Heart Failure
A 12=week, multicenter, double-blind, randomized, placebo-controlled trial of imazodan, a type Ill phosphodiisterase inhibitor, was conducted in 147 patients with congestive heart failure to determine clinical efficacy and safety. Patients were randomized to placebo or 2,s or 10 mg of imazodan administered twice daily. Patients were maintained on their standard therapy including diuretics, digo...
متن کاملHuangqi injection in the treatment of chronic heart failure
BACKGROUND To evaluate the clinical effectiveness and safety of Huangqi injection (HI) in treating chronic heart failure (CHF) systematically. METHODS A literature search was conducted for retrieving randomized controlled trials (RCTs) on CHF treated by HI in the Cochrane Library, PubMed, Embase, China Biology Medicine disc, China National Knowledge Infrastructure Database, China Science and ...
متن کاملBisoprolol in the treatment of chronic heart failure
Bisoprolol fumarate is a highly selective beta-1 receptor blocker. Bisoprolol has been extensively studied in three large mortality trials in stable chronic heart failure (CHF) patients. The CIBIS trial enrolled 641 patients and demonstrated the good tolerability of bisoprolol in a large CHF population, without evidence for any harmful effect. The CIBIS-II study was the first large randomized, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1958
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.2.5107.1284